abstract |
The present invention relates to asialointerferon for treating liver cancer, comprising asialointerferon-α, asialointerferon-α2a, asialointerferon-α2b, asialointerferon-β, asialointerferon-β1a, asialointerferon-β1b and asialointerferon-γ. It is characterized by its preparation and use. Asialo interferon therapy can be used alone or in combination with other anti-neoplastic therapies. |